A multicenter, prospective, real-world study on the treatment of stable chronic obstructive pulmonary disease with Guben Kechuan granules

Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital0 个研究点开始时间: 待定最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Meets the diagnostic criteria of Western medicine for chronic obstructive pulmonary disease; 2. Meets the diagnostic criteria for the lung kidney deficiency syndrome of chronic obstructive pulmonary disease in traditional Chinese medicine; 3. Chronic obstructive pulmonary disease is clinically stable, with no respiratory infections or AECOPD in the past 4 weeks; 4. Aged 18-80 years old, regardless of gender; 5. Volunteer to receive treatment and sign an informed consent form.

•1. Patients with airflow restriction caused by asthma, bronchiectasis, and pulmonary fibrosis; 2. Those who have undergone lung transplantation or pneumonectomy; 3. Patients with severe hypertension, heart failure, arrhythmia, diabetes, primary heart, liver, kidney, blood, nervous system symptoms and other poor control; 4. Lung tumors, malignant tumors (less than 5 years from initial diagnosis, or with recurrence or metastasis confirmed by imaging or tumor markers, or undergoing radiotherapy, chemotherapy, targeted therapy, immunotherapy, etc.); 5. Individuals who are allergic to known drug ingredients; 6. Pregnant, planned or lactating women; 7. Researchers believe that it is not suitable for inclusion in the study.

发起方

Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital